Implantable cardioverter defibrillator utilization and mortality among patients ≥ 65 years of age with a low ejection fraction following coronary revascularization
The American Journal of Cardiology Oct 18, 2020
Goldstein SA, Li S, Matsouaka RA, et al. - Researchers sought to determine implantable cardioverter-defibrillator (ICD) utilization as well as its link with death among patients ≥ 65 years of age after coronary revascularization. For this purpose, the NCDR Chest Pain-Myocardial Infarction (MI) Registry was used as well as Medicare claims. The link between ICD implantation and 2-year mortality was examined. This analysis involved 11,661 patients, including 1,234 (10.6%) who underwent ICD implantation within 1 year of revascularization (1063 (10.6%) percutaneous coronary intervention and 171 (10.4%) coronary artery bypass grafting). Findings revealed that an ICD within 1 year post-revascularization was received by only 1 in 10 Medicare patients with low ejection fraction. A higher chance of ICD implantation was noted in relation to contact with the healthcare system post-discharge. Lower mortality after revascularization for MI was observed in relation to ICD implantation.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries